Select the name of the type of clinical care program you would like more information about …

Example: ‘B’ for Bladder Cancer

Cancer Treatment A-Z

Skip to content. | Skip to navigation

Personal tools

Navigation

You are here: Home / News / 2012 News / UNC team describes novel inflammatory protein function

UNC team describes novel inflammatory protein function

by maryruth.helms — last modified Aug 14, 2012 10:02 AM
A UNC-led team of scientists describes the function of a previously uncharacterized protein that dramatically influences inflammation.
UNC team describes novel inflammatory protein function

Jenny Ting, PhD, is senior author of the paper.

A majority of the NLRExternal Site family of proteins function as activators of inflammation. However, scientists at UNC report that a newly identified NLR protein, NLRC3, was able to inhibit a major inflammatory pathway that is controlled by a protein called NF-Kappa B. NF-Kappa B activation has been long associated with inflammation and cancer promotion. Their article appears in the August 5,2012 online publication of the journal Nature ImmunologyExternal Site.

The UNC team previously reported that another NLR family member, NLRP12, was also able to inhibit NF-Kappa B activation.  However, in their new study, the team reported that NLRC3 inhibits this major inflammatory pathway through a completely different mechanism.  The researchers show that NLRC3 directly interacts with the molecule TRAF6 and forms a novel, previously uncharacterized protein complex described as a ‘TRAFasome’.  TRAF6 is a key regulator of NF-kappaB and is a critical step in the regulation of inflammation.

In pre-clinical models, the team was able to show that NLRC3 and the formation of the TRAFasome was important in regulating the immune response during endotoxic shock, a serious hyperinflammatory process typically associated with severe infection.

Monika Schneider, first author of the paper and a postdoctoral research associate at UNC Lineberger Comprehensive Cancer Center, explains, “Our research reveals greater insight into the mechanisms controlling inflammation and identifies potential therapeutic targets.”

Schneider is in the laboratory of Jenny Ting, PhD, UNC Alumni Distinguished Professor of Microbiology and Immunology and director of the Inflammation center at UNC. Ting is a pioneer in the understanding of the NLR family of proteins. She is co-leader of UNC Lineberger’s Immunology Program and senior author of the Nature Immunology paper.

Other UNC-based authors are: Albert Zimmermann, PhD; Reid  Roberts, MD/PhD graduate student; Lu Zhang, PhD graduate student; Karen Swanson, PhD; Haitao Wen, PhD; Irving C. Allen, PhD; Timothy Eitas, PhD; and Beverly Koller, PhD. Other authors formerly at UNC: Beckley Davis, PhD; Eda Holl, PhD; Zhengmao Ye, PhD; Adeeb Rahman,PhD; and Brian Conti, PhD

Funding for the study was provided by the National Institutes of Health: R37-AI029564, U54-AI057157, U19-AI1077437 and T32-AR007416.

Filed under: ,